Applicability of a Prognostic CT-based Radiomic Signature Model Trained on Stage I-Iii Non-Small Cell Lung Cancer in Stage IV Non-Small Cell Lung Cancer

Lung Cancer - Netherlands
doi 10.1016/j.lungcan.2018.07.023
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

CT-Based Radiomic Signature as a Prognostic Factor in Stage IV ALK-Positive Non-Small-Cell Lung Cancer Treated With TKI Crizotinib: A Proof-Of-Concept Study

Frontiers in Oncology
Cancer ResearchOncology
2020English

Neoadjuvant Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer

Frontiers in Oncology
Cancer ResearchOncology
2017English

P1.16-03 Prognostic Significance of PD-L1 in Stage II/III Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Patterns of Care for Stage III Non-Small Cell Lung Cancer in Australia

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2019English

Image Features for the Future in Stage IV Non-Small Cell Lung Cancer

English

Expression and Prognostic Role of IKBKE and TBK1 in Stage I Non-Small Cell Lung Cancer

Cancer Management and Research
Oncology
2019English

Improved Detection of Stage I Non–small Cell Lung Cancer With a Serum-Based Assay

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2015English

Pembrolizumab-Induced Obstructive Bronchiolitis in a Patient With Stage IV Non-Small-Cell Lung Cancer

Current Oncology
Oncology
2019English

Correction: Methylation Markers of Early-Stage Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy